Loading…
Aruba Aloe Balm N.V., a drug manufacturing facility in Aruba, violated Current Good Manufacturing Practice (CGMP) regulations during an FDA inspection in November 2023, resulting in findings that their drug products were adulterated. The company failed to test incoming components and active pharmaceutical ingredients for identity, purity, strength, and quality as required, instead only performing basic physiochemical checks like appearance and smell assessments. Additionally, their product "Island Remedy All-Day Revitalizing Moisturizer" was found to be misbranded, making it prohibited from introduction into interstate commerce.